Related references
Note: Only part of the references are listed.被撤回的出版物: Bio-HMGB1 from breast cancer contributes to M-MDSC differentiation from bone marrow progenitor cells and facilitates conversion of monocytes into MDSC-like cells (Retracted Article)
Zhaoliang Su et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
High-dose dexamethasone or all-trans-retinoic acid restores the balance of macrophages towards M2 in immune thrombocytopenia
Q. Feng et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Generation and functional characterization of MDSC-like cells
Annkristin Heine et al.
ONCOIMMUNOLOGY (2017)
High-dose dexamethasone corrects impaired myeloid-derived suppressor cell function via Ets1 in immune thrombocytopenia
Yu Hou et al.
BLOOD (2016)
Thrombopoietin receptor agonists shift the balance of Fcγ receptors toward inhibitory receptor IIb on monocytes in ITP
Xin-guang Liu et al.
BLOOD (2016)
Myeloid-derived suppressor cells contribute to bone erosion in collagen-induced arthritis by differentiating to osteoclasts
Hui Zhang et al.
JOURNAL OF AUTOIMMUNITY (2015)
TLR9 ligation in pancreatic stellate cells promotes tumorigenesis
Constantinos P. Zambirinis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages
Takanori Kitamura et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma
Oscar W. H. Yeung et al.
JOURNAL OF HEPATOLOGY (2015)
Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy
Oana Draghiciu et al.
ONCOIMMUNOLOGY (2015)
Insufficient secretion of IL-10 by Tregs compromised its control on over-activated CD4+ T effector cells in newly diagnosed adult immune thrombocytopenia patients
Feng Li et al.
IMMUNOLOGIC RESEARCH (2015)
Identification of myeloid-derived suppressor cells in the synovial fluid of patients with rheumatoid arthritis: a pilot study
Julia Kurko et al.
BMC MUSCULOSKELETAL DISORDERS (2014)
Role of macrophage inflammatory protein (MIP)-1α/CCL3 in leukemogenesis
Tomohisa Baba et al.
MOLECULAR & CELLULAR ONCOLOGY (2014)
Preferential splenic CD8+ T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia
Sylvain Audia et al.
BLOOD (2013)
Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
Melanie Bruchard et al.
NATURE MEDICINE (2013)
Induction of M2-macrophages by tumour cells and tumour growth promotion by M2-macrophages: A quid pro quo in pancreatic cancer
L. I. Partecke et al.
PANCREATOLOGY (2013)
Defective regulatory B-cell compartment in patients with immune thrombocytopenia
Xiaojuan Li et al.
BLOOD (2012)
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury
Christer Baeck et al.
GUT (2012)
Activation of Invariant NKT Cells in Early Phase of Experimental Autoimmune Encephalomyelitis Results in Differentiation of Ly6Chi Inflammatory Monocyte to M2 Macrophages and Improved Outcome
Laura Denney et al.
JOURNAL OF IMMUNOLOGY (2012)
Myeloid-Derived Suppressor Cells Limit the Inflammation by Promoting T Lymphocyte Apoptosis in the Spinal Cord of a Murine Model of Multiple Sclerosis
Veronica Moline-Velazquez et al.
BRAIN PATHOLOGY (2011)
MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy
James Finke et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Caspase-1-Processed Cytokines IL-1β and IL-18 Promote IL-17 Production by γδ and CD4 T Cells That Mediate Autoimmunity
Stephen J. Lalor et al.
JOURNAL OF IMMUNOLOGY (2011)
Excess Circulating Alternatively Activated Myeloid (M2) Cells Accelerate ALS Progression While Inhibiting Experimental Autoimmune Encephalomyelitis
Ilan Vaknin et al.
PLOS ONE (2011)
The interaction between different types of activated RAW 264.7 cells and macrophage inflammatory protein-1 alpha
Zhongshi He et al.
RADIATION ONCOLOGY (2011)
Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function
Thomas Condamine et al.
TRENDS IN IMMUNOLOGY (2011)
International consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD (2010)
Tolerogenic dendritic cells and myeloid-derived suppressor cells: Potential for regulation and therapy of liver auto- and alloimmunity
Sudha Natarajan et al.
IMMUNOBIOLOGY (2010)
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Francesco Rodeghiero et al.
BLOOD (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura
Jin Yu et al.
BLOOD (2008)
A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+CD25+Foxp3+ T cells
Bastian Hoechst et al.
GASTROENTEROLOGY (2008)
The role of myeloid cells in the promotion of tumour angiogenesis
Craig Murdoch et al.
NATURE REVIEWS CANCER (2008)
Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft
Silvina Gazzaniga et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response
Pratima Sinha et al.
JOURNAL OF IMMUNOLOGY (2007)
Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor based antitumor vaccine
Paola Filipazzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Interleukin-1β dxon 5 and interleukin-1 receptor antagonist in children with immune thrombocytopenic purpura
Kang-Hsi Wu et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2007)
Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience
Maria Gabriella Mazzucconi et al.
BLOOD (2007)
Defective antitumor function of monocyte-derived macrophages from epithelial ovarian cancer patients
IO Gordon et al.
CLINICAL CANCER RESEARCH (2006)
Role of immature myeloid Gr-1+ cells in the development of antitumor immunity
QS Li et al.
CANCER RESEARCH (2004)
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
YF Cheng et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Toll-like receptors and innate immunity
R Medzhitov
NATURE REVIEWS IMMUNOLOGY (2001)
Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells
M Nesbit et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
